Biography
Biography
After nearly two decades of presiding over some of South Florida’s most complex, notorious and precedent-setting cases, Eleventh Judicial Circuit Judge Ronald C. Dresnick joined Kluger Kaplan to focus on trial work including complex commercial and probate litigation, white-collar defense, securities litigation and internal investigations. Additionally, he provides law firms litigation support with jury selection, motion and trial analysis. In addition to his accomplished career in civil litigation, Dresnick is a proficient practitioner in Alternative Dispute Resolution (ADR), providing clients with efficient and effective dispute resolution beyond traditional court proceedings, including both mediations and arbitrations
Judge Dresnick is known for having heard some of the most significant cases impacting the South Florida judiciary and broader community including the Major League Baseball steroid controversy involving South Florida clinic Biogenesis; a $100 million claim against Cuba for acts of terror tied to the Bay of Pigs; a major case resulting in a recent Florida Supreme Court decision reversing the lower appellate court and upholding Dresnick’s definition of the legal concept of the scope of duty; and an ethical matter that has become required reading in professionalism courses across the nation. Judge Dresnick also handled a case of first impression, relating to a victim’s attempt to enforce a wrongful death judgment against the Miccosukee Tribe.
Dresnick was appointed to the Circuit Bench by Florida Governor Lawton Chiles in 1996 and was re-elected without opposition during each election he faced over his 18-year tenure. He served in the Civil, Criminal and Family Divisions.
Education
Education
- Harvard Law School, Master of Laws (LLM)
- University of Miami School of Law, J.D. with honors
Bar Admissions and Memberships
Bar Admissions and Memberships
- Florida
Awards and Publications
Awards and Publications
Awards
- Best Lawyers in America, Arbitration, Mediation, Commercial Litigation, 2025